CPDA-1
- Product NDC
- 0942-6322
- 11-digit product format
- 009426322
- Labeler code
- 0942
- Product ID
- 0942-6322_f7b9be90-d870-40af-ae22-abf675d89784
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anticoagulant Citrate Phosphate Dextrose Adenine
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fenwal, Inc.
- Application
- BN770420
- Marketing category
- NDA
- Marketing start
- 2007-06-24
- Substance
- ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE
- Active strength
- 17.3; 188; 2; 140; 1.66 mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL
- Pharmacologic classes
- Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CPDA-1
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ADENINE | 17.3 mg/63mL |
| ANHYDROUS CITRIC ACID | 188 mg/63mL |
| DEXTROSE MONOHYDRATE | 2 g/63mL |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 140 mg/63mL |
| TRISODIUM CITRATE DIHYDRATE | 1.66 g/63mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JAC85A2161, XF417D3PSL, LX22YL083G, 593YOG76RN, B22547B95K |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0942-6322-04 | CPDA-1 | 63 mL in 1 BAG | SOLUTION | 63 | | 7 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Adenine | ACTIVE INGREDIENT | JAC85A2161 | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Anhydrous Citric Acid | ACTIVE INGREDIENT | XF417D3PSL | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Dextrose Monohydrate | ACTIVE INGREDIENT | LX22YL083G | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Adenine | ACTIVE MOIETY | JAC85A2161 | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Anhydrous Citric Acid | ACTIVE MOIETY | XF417D3PSL | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0942-6322 | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20210617_e41adb4e-06fb-4141-ba55-50b043f3c9da.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0942-6322-04 | 00942632204 | 63 mL in 1 BAG (0942-6322-04) | 63 ml | 2007-06-24 | 0000-00-00 | No | No | Current |